Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Vaccination of Two EV71 Inactivated Vaccines in Infants
NCT03873740Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Nov 2018
- Primary completion
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), sponsored by Sinovac Biotech Ltd.. Started Nov 2018; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT03873740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03873740.